IGF2BP1 was showed to highly express in neuroblastoma tissues and identified as a significantly important gene in this disease because of its clear negative prognostic effect at the DNA, mRNA, and protein levels, and its positive correlation with MYCN, a most prominent oncogene in neuroblastoma and other aggressive tumors. The gene discussed is IGF2BP1; the disease is neuroblastoma.